Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with liver cancer (hepatocellular carcinoma) confirmed by a tissue sample, OR you have been diagnosed with liver cirrhosis (scarring of the liver) without liver cancer (as a comparison group)
- You are willing and able to give your informed agreement to take part in the study
- You have both a blood (plasma) sample and a liver tissue sample available for testing
Who may not be able to join:
- You currently have another type of active cancer
- You have previously had a liver transplant
- You have a known hereditary (genetic) cancer syndrome that runs in your family
- You have received chemotherapy or antiviral treatment within the last 3 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +5492616603254
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and Specificity of delta-HLD Technology
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.